866-997-4948(US-Canada Toll Free)

United States Cardiac Biomarker Market Report 2017

Published By :

QYResearch

Published Date : Apr 2017

Category :

Pharmaceutical

No. of Pages : 95 Pages

In this report, the United States Cardiac Biomarker market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Cardiac Biomarker in these regions, from 2012 to 2022 (forecast).

United States Cardiac Biomarker market competition by top manufacturers/players, with Cardiac Biomarker sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Alere
Roche Diagnostics
BG Medicine
Biomerieux
Critical Diagnostics
DiaDexus
BD Biosciences
Biocompare

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Creatine Kinase (CK) MB
Troponin (cTnI and cTnT)
BNP & NT-proBNP
Myogloblin
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cardiac Biomarker for each application, including
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Cardiac Biomarker Market Report 2017
1 Cardiac Biomarker Overview
1.1 Product Overview and Scope of Cardiac Biomarker
1.2 Classification of Cardiac Biomarker by Product Category
1.2.1 United States Cardiac Biomarker Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Cardiac Biomarker Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Creatine Kinase (CK) MB
1.2.4 Troponin (cTnI and cTnT)
1.2.5 BNP & NT-proBNP
1.2.6 Myogloblin
1.2.7 Others
1.3 United States Cardiac Biomarker Market by Application/End Users
1.3.1 United States Cardiac Biomarker Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 United States Cardiac Biomarker Market by Region
1.4.1 United States Cardiac Biomarker Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Cardiac Biomarker Status and Prospect (2012-2022)
1.4.3 Southwest Cardiac Biomarker Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Cardiac Biomarker Status and Prospect (2012-2022)
1.4.5 New England Cardiac Biomarker Status and Prospect (2012-2022)
1.4.6 The South Cardiac Biomarker Status and Prospect (2012-2022)
1.4.7 The Midwest Cardiac Biomarker Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cardiac Biomarker (2012-2022)
1.5.1 United States Cardiac Biomarker Sales and Growth Rate (2012-2022)
1.5.2 United States Cardiac Biomarker Revenue and Growth Rate (2012-2022)

2 United States Cardiac Biomarker Market Competition by Players/Suppliers
2.1 United States Cardiac Biomarker Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cardiac Biomarker Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cardiac Biomarker Average Price by Players/Suppliers (2012-2017)
2.4 United States Cardiac Biomarker Market Competitive Situation and Trends
2.4.1 United States Cardiac Biomarker Market Concentration Rate
2.4.2 United States Cardiac Biomarker Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cardiac Biomarker Manufacturing Base Distribution, Sales Area, Product Type

3 United States Cardiac Biomarker Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Cardiac Biomarker Sales and Market Share by Region (2012-2017)
3.2 United States Cardiac Biomarker Revenue and Market Share by Region (2012-2017)
3.3 United States Cardiac Biomarker Price by Region (2012-2017)

4 United States Cardiac Biomarker Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Cardiac Biomarker Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cardiac Biomarker Revenue and Market Share by Type (2012-2017)
4.3 United States Cardiac Biomarker Price by Type (2012-2017)
4.4 United States Cardiac Biomarker Sales Growth Rate by Type (2012-2017)

5 United States Cardiac Biomarker Sales (Volume) by Application (2012-2017)
5.1 United States Cardiac Biomarker Sales and Market Share by Application (2012-2017)
5.2 United States Cardiac Biomarker Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Cardiac Biomarker Players/Suppliers Profiles and Sales Data
6.1 Alere
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Cardiac Biomarker Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Alere Cardiac Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Roche Diagnostics
6.2.2 Cardiac Biomarker Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Roche Diagnostics Cardiac Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 BG Medicine
6.3.2 Cardiac Biomarker Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 BG Medicine Cardiac Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Biomerieux
6.4.2 Cardiac Biomarker Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Biomerieux Cardiac Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Critical Diagnostics
6.5.2 Cardiac Biomarker Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Critical Diagnostics Cardiac Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 DiaDexus
6.6.2 Cardiac Biomarker Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 DiaDexus Cardiac Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 BD Biosciences
6.7.2 Cardiac Biomarker Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 BD Biosciences Cardiac Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Biocompare
6.8.2 Cardiac Biomarker Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Biocompare Cardiac Biomarker Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview

7 Cardiac Biomarker Manufacturing Cost Analysis
7.1 Cardiac Biomarker Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cardiac Biomarker

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Cardiac Biomarker Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cardiac Biomarker Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Cardiac Biomarker Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Cardiac Biomarker Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cardiac Biomarker Sales Volume Forecast by Type (2017-2022)
11.3 United States Cardiac Biomarker Sales Volume Forecast by Application (2017-2022)
11.4 United States Cardiac Biomarker Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Cardiac Biomarker
Figure United States Cardiac Biomarker Market Size (K Units) by Type (2012-2022)
Figure United States Cardiac Biomarker Sales Volume Market Share by Type (Product Category) in 2016
Figure Creatine Kinase (CK) MB Product Picture
Figure Troponin (cTnI and cTnT) Product Picture
Figure BNP & NT-proBNP Product Picture
Figure Myogloblin Product Picture
Figure Others Product Picture
Figure United States Cardiac Biomarker Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Cardiac Biomarker by Application in 2016
Figure Myocardial Infarction Examples
Figure Congestive Heart Failure Examples
Figure Acute Coronary Syndrome Examples
Figure Atherosclerosis Examples
Figure Others Examples
Figure United States Cardiac Biomarker Market Size (Million USD) by Region (2012-2022)
Figure The West Cardiac Biomarker Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cardiac Biomarker Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cardiac Biomarker Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cardiac Biomarker Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cardiac Biomarker Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cardiac Biomarker Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cardiac Biomarker Sales (K Units) and Growth Rate (2012-2022)
Figure United States Cardiac Biomarker Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cardiac Biomarker Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Cardiac Biomarker Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Cardiac Biomarker Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cardiac Biomarker Sales Share by Players/Suppliers
Figure 2017 United States Cardiac Biomarker Sales Share by Players/Suppliers
Figure United States Cardiac Biomarker Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cardiac Biomarker Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cardiac Biomarker Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cardiac Biomarker Revenue Share by Players/Suppliers
Figure 2017 United States Cardiac Biomarker Revenue Share by Players/Suppliers
Table United States Market Cardiac Biomarker Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Cardiac Biomarker Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Cardiac Biomarker Market Share of Top 3 Players/Suppliers
Figure United States Cardiac Biomarker Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cardiac Biomarker Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cardiac Biomarker Product Category
Table United States Cardiac Biomarker Sales (K Units) by Region (2012-2017)
Table United States Cardiac Biomarker Sales Share by Region (2012-2017)
Figure United States Cardiac Biomarker Sales Share by Region (2012-2017)
Figure United States Cardiac Biomarker Sales Market Share by Region in 2016
Table United States Cardiac Biomarker Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cardiac Biomarker Revenue Share by Region (2012-2017)
Figure United States Cardiac Biomarker Revenue Market Share by Region (2012-2017)
Figure United States Cardiac Biomarker Revenue Market Share by Region in 2016
Table United States Cardiac Biomarker Price (USD/Unit) by Region (2012-2017)
Table United States Cardiac Biomarker Sales (K Units) by Type (2012-2017)
Table United States Cardiac Biomarker Sales Share by Type (2012-2017)
Figure United States Cardiac Biomarker Sales Share by Type (2012-2017)
Figure United States Cardiac Biomarker Sales Market Share by Type in 2016
Table United States Cardiac Biomarker Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cardiac Biomarker Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cardiac Biomarker by Type (2012-2017)
Figure Revenue Market Share of Cardiac Biomarker by Type in 2016
Table United States Cardiac Biomarker Price (USD/Unit) by Types (2012-2017)
Figure United States Cardiac Biomarker Sales Growth Rate by Type (2012-2017)
Table United States Cardiac Biomarker Sales (K Units) by Application (2012-2017)
Table United States Cardiac Biomarker Sales Market Share by Application (2012-2017)
Figure United States Cardiac Biomarker Sales Market Share by Application (2012-2017)
Figure United States Cardiac Biomarker Sales Market Share by Application in 2016
Table United States Cardiac Biomarker Sales Growth Rate by Application (2012-2017)
Figure United States Cardiac Biomarker Sales Growth Rate by Application (2012-2017)
Table Alere Basic Information List
Table Alere Cardiac Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alere Cardiac Biomarker Sales Growth Rate (2012-2017)
Figure Alere Cardiac Biomarker Sales Market Share in United States (2012-2017)
Figure Alere Cardiac Biomarker Revenue Market Share in United States (2012-2017)
Table Roche Diagnostics Basic Information List
Table Roche Diagnostics Cardiac Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Diagnostics Cardiac Biomarker Sales Growth Rate (2012-2017)
Figure Roche Diagnostics Cardiac Biomarker Sales Market Share in United States (2012-2017)
Figure Roche Diagnostics Cardiac Biomarker Revenue Market Share in United States (2012-2017)
Table BG Medicine Basic Information List
Table BG Medicine Cardiac Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BG Medicine Cardiac Biomarker Sales Growth Rate (2012-2017)
Figure BG Medicine Cardiac Biomarker Sales Market Share in United States (2012-2017)
Figure BG Medicine Cardiac Biomarker Revenue Market Share in United States (2012-2017)
Table Biomerieux Basic Information List
Table Biomerieux Cardiac Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biomerieux Cardiac Biomarker Sales Growth Rate (2012-2017)
Figure Biomerieux Cardiac Biomarker Sales Market Share in United States (2012-2017)
Figure Biomerieux Cardiac Biomarker Revenue Market Share in United States (2012-2017)
Table Critical Diagnostics Basic Information List
Table Critical Diagnostics Cardiac Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Critical Diagnostics Cardiac Biomarker Sales Growth Rate (2012-2017)
Figure Critical Diagnostics Cardiac Biomarker Sales Market Share in United States (2012-2017)
Figure Critical Diagnostics Cardiac Biomarker Revenue Market Share in United States (2012-2017)
Table DiaDexus Basic Information List
Table DiaDexus Cardiac Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DiaDexus Cardiac Biomarker Sales Growth Rate (2012-2017)
Figure DiaDexus Cardiac Biomarker Sales Market Share in United States (2012-2017)
Figure DiaDexus Cardiac Biomarker Revenue Market Share in United States (2012-2017)
Table BD Biosciences Basic Information List
Table BD Biosciences Cardiac Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BD Biosciences Cardiac Biomarker Sales Growth Rate (2012-2017)
Figure BD Biosciences Cardiac Biomarker Sales Market Share in United States (2012-2017)
Figure BD Biosciences Cardiac Biomarker Revenue Market Share in United States (2012-2017)
Table Biocompare Basic Information List
Table Biocompare Cardiac Biomarker Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biocompare Cardiac Biomarker Sales Growth Rate (2012-2017)
Figure Biocompare Cardiac Biomarker Sales Market Share in United States (2012-2017)
Figure Biocompare Cardiac Biomarker Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cardiac Biomarker
Figure Manufacturing Process Analysis of Cardiac Biomarker
Figure Cardiac Biomarker Industrial Chain Analysis
Table Raw Materials Sources of Cardiac Biomarker Major Players/Suppliers in 2016
Table Major Buyers of Cardiac Biomarker
Table Distributors/Traders List
Figure United States Cardiac Biomarker Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Cardiac Biomarker Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cardiac Biomarker Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Cardiac Biomarker Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cardiac Biomarker Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cardiac Biomarker Sales Volume (K Units) Forecast by Type in 2022
Table United States Cardiac Biomarker Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cardiac Biomarker Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cardiac Biomarker Sales Volume (K Units) Forecast by Application in 2022
Table United States Cardiac Biomarker Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Cardiac Biomarker Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cardiac Biomarker Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cardiac Biomarker Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *